Long-term follow up of patients with dilated heart muscle disease treated with human leucocytic interferon alpha or thymic hormones initial results.
- 1 June 1996
- Vol. 75 (6), 596-601
- https://doi.org/10.1136/hrt.75.6.596
Abstract
To determine whether giving interferon-alpha or thymomodulin in addition to conventional treatment improves cardiac function in patients with idiopathic myocarditis and idiopathic dilated cardiomyopathy. Single-centre, randomised, open label, parallel group comparison of conventional treatment plus interferon-alpha, conventional treatment plus thymomodulin, and conventional treatment alone. 38 patients aged 19-54 years (23 men) with biopsy-proven myocarditis or dilated cardiomyopathy. 12 were treated with conventional treatment alone, 13 were treated with interferon-alpha and conventional treatment, and 13 with thymomodulin and conventional treatment. Tertiary cardiac referral centre. Clinical evaluation, echocardiography, and Holter monitoring at baseline, 6 months, and 1 and 2 years. Radionuclide ventriculography at rest and during exercise after 2 years. Endomyocardial biopsy at baseline and after a year if the initial diagnosis was myocarditis. Left ventricular ejection fraction was improved in 21 (81%) of 26 patients after interferon-alpha or thymomodulin administration and in 8 (66%) of 12 conventionally treated patients (P < 0.05) at 2 year follow up. The maximum exercise time was significantly longer at 2-year follow up in patients treated with immunomodulators (mean (SEM) 5.1 (0.6) minutes for interferon-alpha and 5.0 (0.4) minutes for thymomodulin) than in conventionally treated patients (3.3 (0.4) minutes). Left ventricular ejection fraction during exercise (assessed by radionuclide ventriculography) improved in 9 of 12 patients treated with interferon-alpha, 10 of 12 patients treated with thymomodulin, and 3 of 9 conventionally treated patients at 2 year follow up. The electrocardiogram was normal in 21 (88%) of 24 patients after interferon-alpha or thymomodulin treatment and 2 (22%) of 9 conventionally treated patients. At 2 year follow up, 19 (73%) of 26 patients treated with immunomodulators and 4 (25%) of 12 conventionally treated patients had improved their functional class. The results suggest that treatment of idiopathic myocarditis and/or idiopathic dilated cardiomyopathy with interferon-alpha or thymomodulin induces an earlier and significantly superior clinical improvement than conventional treatment alone.Keywords
This publication has 20 references indexed in Scilit:
- A Clinical Trial of Immunosuppressive Therapy for MyocarditisNew England Journal of Medicine, 1995
- Detection of enteroviral RNA in idiopathic dilated cardiomyopathy and other human cardiac tissues.JCI Insight, 1992
- Reversible cardiomyopathy induced by interferon.BMJ, 1990
- Reversible Cardiac Dysfunction Associated with Interferon Alfa Therapy in AIDS Patients with Kaposi's SarcomaNew England Journal of Medicine, 1989
- Persistence of Enterovirus RNA in Dilated Cardiomyopathy: A Progression from MyocarditisPublished by Springer Science and Business Media LLC ,1988
- DETECTION OF COXSACKIE-B-VIRUS-SPECIFIC RNA SEQUENCES IN MYOCARDIAL BIOPSY SAMPLES FROM PATIENTS WITH MYOCARDITIS AND DILATED CARDIOMYOPATHYThe Lancet, 1986
- The Effects of Long-Term Administration of Recombinant Alpha-2 Interferon on Lymphocyte Subsets, Proliferation, and Suppressor Cell Function in Multiple SclerosisJournal of Interferon Research, 1986
- Sendai Virus Infection in the Brains of Mice: Distribution of Viral Antigens Studied with Monoclonal AntibodiesThe Journal of Infectious Diseases, 1983
- Restricted expression of viral glycoprotein in cells of persistently infected miceNature, 1982
- Cytotoxicity against the K562 erythroleukemia cell line by human natural killer (NK) cells which do not bear free Fc receptors for IgGInternational Journal of Cancer, 1979